MicroPort Endovascular Medtech Obtains Regulatory Approval for Detachable Fibered Embolic Coil

Stock News
03/13

Shanghai Microport Endovascular Medtech (Group) Co., Ltd. (688016.SH) has announced that its subsidiary, Shanghai Hongmai Medical Technology Co., Ltd., recently received a medical device registration certificate from the National Medical Products Administration for a detachable fibered embolic coil. The HawkMaster™/LongYuan™ detachable fibered embolic coil is the company's second coil embolization product approved for market launch, following the HawkNest™/YingChao™ fibered embolic coil. The introduction of this product further enriches the company's portfolio in the peripheral artery field and enhances its product offerings in the peripheral vascular interventional therapy sector.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10